» Articles » PMID: 36710868

Mesenchymal Stem Cell-derived Extracellular Vesicles, Osteoimmunology and Orthopedic Diseases

Overview
Journal PeerJ
Date 2023 Jan 30
PMID 36710868
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells (MSCs) play an important role in tissue healing and regenerative medicine due to their self-renewal and multi-directional differentiation properties. MSCs exert their therapeutic effects mainly via the paracrine pathway, which involves the secretion of extracellular vesicles (EVs). EVs have a high drug loading capacity and can transport various molecules, such as proteins, nucleic acids, and lipids, that can modify the course of diverse diseases. Due to their ability to maintain the therapeutic effects of their parent cells, MSC-derived EVs have emerged as a promising, safe cell-free treatment approach for tissue regeneration. With advances in inflammation research and emergence of the field of osteoimmunology, evidence has accumulated pointing to the role of inflammatory and osteoimmunological processes in the occurrence and progression of orthopedic diseases. Several studies have shown that MSC-derived EVs participate in bone regeneration and the pathophysiology of orthopedic diseases by regulating the inflammatory environment, enhancing angiogenesis, and promoting the differentiation and proliferation of osteoblasts and osteoclasts. In this review, we summarize recent advances in the application and functions of MSC-derived EVs as potential therapies against orthopedic diseases, including osteoarthritis, intervertebral disc degeneration, osteoporosis and osteonecrosis.

Citing Articles

Current status of nano-embedded growth factors and stem cells delivery to bone for targeted repair and regeneration.

Liang W, Zhou C, Liu X, Xie Q, Xia L, Liu L J Orthop Translat. 2025; 50:257-273.

PMID: 39902262 PMC: 11788687. DOI: 10.1016/j.jot.2024.12.006.


The role of toll-like receptors in orchestrating osteogenic differentiation of mesenchymal stromal cells and osteoimmunology.

Liu X, Zhou Z, Zeng W, Zeng Q, Zhang X Front Cell Dev Biol. 2023; 11:1277686.

PMID: 37941898 PMC: 10629627. DOI: 10.3389/fcell.2023.1277686.


Harnessing Stem Cell-Derived Extracellular Vesicles for the Regeneration of Degenerative Bone Conditions.

Jia Z, Zhang S, Li W Int J Nanomedicine. 2023; 18:5561-5578.

PMID: 37795043 PMC: 10546935. DOI: 10.2147/IJN.S424731.


Mesenchymal Stromal Cells-Derived Extracellular Vesicles as Potential Treatments for Osteoarthritis.

Yuan S, Li G, Zhang J, Chen X, Su J, Zhou F Pharmaceutics. 2023; 15(7).

PMID: 37514001 PMC: 10385170. DOI: 10.3390/pharmaceutics15071814.


Application of stem cells in regeneration medicine.

Jin Y, Li S, Yu Q, Chen T, Liu D MedComm (2020). 2023; 4(4):e291.

PMID: 37337579 PMC: 10276889. DOI: 10.1002/mco2.291.


References
1.
Xia C, Zeng Z, Fang B, Tao M, Gu C, Zheng L . Mesenchymal stem cell-derived exosomes ameliorate intervertebral disc degeneration via anti-oxidant and anti-inflammatory effects. Free Radic Biol Med. 2019; 143:1-15. DOI: 10.1016/j.freeradbiomed.2019.07.026. View

2.
Dimitriou R, Jones E, McGonagle D, Giannoudis P . Bone regeneration: current concepts and future directions. BMC Med. 2011; 9:66. PMC: 3123714. DOI: 10.1186/1741-7015-9-66. View

3.
Zhang W, Ge W, Li C, You S, Liao L, Han Q . Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev. 2004; 13(3):263-71. DOI: 10.1089/154732804323099190. View

4.
Todorova D, Simoncini S, Lacroix R, Sabatier F, Dignat-George F . Extracellular Vesicles in Angiogenesis. Circ Res. 2017; 120(10):1658-1673. PMC: 5426696. DOI: 10.1161/CIRCRESAHA.117.309681. View

5.
Freemont A, Watkins A, Le Maitre C, Jeziorska M, Hoyland J . Current understanding of cellular and molecular events in intervertebral disc degeneration: implications for therapy. J Pathol. 2002; 196(4):374-9. DOI: 10.1002/path.1050. View